
Sabiha Naim Qazi
Examiner (ID: 14019, Phone: (571)272-0622 , Office: P/1621 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1621, 1611, 1627, 1202, 1616, 1612, 1629, 1628 |
| Total Applications | 2032 |
| Issued Applications | 930 |
| Pending Applications | 195 |
| Abandoned Applications | 909 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4734395
[patent_doc_number] => 20080051375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'METHODS FOR TREATING CANCER COMPRISING THE ADMINISTRATION OF A VITAMIN D COMPOUND AND AN ADDITIONAL THERAPEUTIC AGENT, AND COMPOSITIONS CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/844445
[patent_app_country] => US
[patent_app_date] => 2007-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8624
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11844445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/844445 | METHODS FOR TREATING CANCER COMPRISING THE ADMINISTRATION OF A VITAMIN D COMPOUND AND AN ADDITIONAL THERAPEUTIC AGENT, AND COMPOSITIONS CONTAINING THE SAME | Aug 23, 2007 | Abandoned |
Array
(
[id] => 5474430
[patent_doc_number] => 20090247596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/309941
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19428
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247596.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309941
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309941 | Thiophenecarboxamide derivatives as EP4 receptor ligands | Aug 9, 2007 | Issued |
Array
(
[id] => 5046491
[patent_doc_number] => 20070265165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'NOVEL HERBICIDES'
[patent_app_type] => utility
[patent_app_number] => 11/828598
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15679
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265165.pdf
[firstpage_image] =>[orig_patent_app_number] => 11828598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/828598 | NOVEL HERBICIDES | Jul 25, 2007 | Abandoned |
Array
(
[id] => 5046600
[patent_doc_number] => 20070265274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => '4-(4-METHYLPIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE FOR TREATING MUTATED-RET KINASE ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/828374
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3331
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11828374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/828374 | 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE FOR TREATING MUTATED-RET KINASE ASSOCIATED DISEASES | Jul 25, 2007 | Abandoned |
Array
(
[id] => 5398415
[patent_doc_number] => 20090318478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'QUINAZOLINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/310025
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7049
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310025
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310025 | Quinazoline derivatives | Jul 23, 2007 | Issued |
Array
(
[id] => 4759972
[patent_doc_number] => 20080312198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 11/782067
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19047
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312198.pdf
[firstpage_image] =>[orig_patent_app_number] => 11782067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/782067 | PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND | Jul 23, 2007 | Abandoned |
Array
(
[id] => 4853203
[patent_doc_number] => 20080318946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Di-amino-substituted heterocyclic compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/879832
[patent_app_country] => US
[patent_app_date] => 2007-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17083
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11879832
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/879832 | Di-amino-substituted heterocyclic compounds and methods of use | Jul 17, 2007 | Issued |
Array
(
[id] => 5029018
[patent_doc_number] => 20070270465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[1-(PYRIDIN-2-YLMETHYL) PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 11/776245
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6597
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270465.pdf
[firstpage_image] =>[orig_patent_app_number] => 11776245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/776245 | CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[1-(PYRIDIN-2-YLMETHYL) PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE | Jul 10, 2007 | Abandoned |
Array
(
[id] => 5210984
[patent_doc_number] => 20070249568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => '17,20(E)-dehydro vitamin D analogs and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/775108
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11285
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249568.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775108
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775108 | 17,20(E)-dehydro vitamin D analogs and their uses | Jul 8, 2007 | Issued |
Array
(
[id] => 5297150
[patent_doc_number] => 20090012076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Tyrosine kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/827109
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31777
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012076.pdf
[firstpage_image] =>[orig_patent_app_number] => 11827109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/827109 | Tyrosine kinase inhibitors | Jul 8, 2007 | Issued |
Array
(
[id] => 5225590
[patent_doc_number] => 20070254857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => '2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses'
[patent_app_type] => utility
[patent_app_number] => 11/775074
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5674
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20070254857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775074 | 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and its uses | Jul 8, 2007 | Issued |
Array
(
[id] => 112711
[patent_doc_number] => 07713952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => '2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/775087
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9270
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775087
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775087 | 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses | Jul 8, 2007 | Issued |
Array
(
[id] => 5028944
[patent_doc_number] => 20070270391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => '2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 11/775042
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10338
[patent_no_of_claims] => 151
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20070270391.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775042 | 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses | Jul 8, 2007 | Issued |
Array
(
[id] => 5016629
[patent_doc_number] => 20070259838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => '17,20(Z)-Dehydro Vitamin D Analogs and Their Uses'
[patent_app_type] => utility
[patent_app_number] => 11/775061
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11478
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259838.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775061
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775061 | 17,20(Z)-dehydro vitamin D analogs and their uses | Jul 8, 2007 | Issued |
Array
(
[id] => 123068
[patent_doc_number] => 07704982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => '2-methylene-19-nor-1α-hydroxy-17-ene-homopregnacalciferol and its uses'
[patent_app_type] => utility
[patent_app_number] => 11/775117
[patent_app_country] => US
[patent_app_date] => 2007-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7775
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775117
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775117 | 2-methylene-19-nor-1α-hydroxy-17-ene-homopregnacalciferol and its uses | Jul 8, 2007 | Issued |
Array
(
[id] => 296078
[patent_doc_number] => 07541349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => '2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone'
[patent_app_type] => utility
[patent_app_number] => 11/767085
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10505
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11767085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/767085 | 2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone | Jun 21, 2007 | Issued |
Array
(
[id] => 4759971
[patent_doc_number] => 20080312197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 11/763250
[patent_app_country] => US
[patent_app_date] => 2007-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19133
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11763250
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/763250 | PHARMACEUTICAL PRODUCTS CONTAINING HORMONES AND A 25-HYDROXY VITAMIN D COMPOUND | Jun 13, 2007 | Abandoned |
Array
(
[id] => 9626566
[patent_doc_number] => 08796246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => '9, 10-secopregnane derivative and pharmaceutical'
[patent_app_type] => utility
[patent_app_number] => 12/302975
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22233
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302975 | 9, 10-secopregnane derivative and pharmaceutical | May 31, 2007 | Issued |
Array
(
[id] => 7768118
[patent_doc_number] => 20120035224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Betulin derived compounds as anti-feedants for plant pests'
[patent_app_type] => utility
[patent_app_number] => 12/308056
[patent_app_country] => US
[patent_app_date] => 2007-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13977
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035224.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308056 | Betulin derived compounds as anti-feedants for plant pests | May 31, 2007 | Abandoned |
Array
(
[id] => 7490913
[patent_doc_number] => 08030295
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => '19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds'
[patent_app_type] => utility
[patent_app_number] => 11/756333
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12093
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/030/08030295.pdf
[firstpage_image] =>[orig_patent_app_number] => 11756333
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/756333 | 19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds | May 30, 2007 | Issued |